| __timestamp | Viatris Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 581800000 | 22223073 |
| Thursday, January 1, 2015 | 671900000 | 6966842 |
| Friday, January 1, 2016 | 876700000 | 9000499 |
| Sunday, January 1, 2017 | 857900000 | 13741186 |
| Monday, January 1, 2018 | 822200000 | 19040000 |
| Tuesday, January 1, 2019 | 778200000 | 23559000 |
| Wednesday, January 1, 2020 | 512600000 | 31931000 |
| Friday, January 1, 2021 | 681000000 | 44981000 |
| Saturday, January 1, 2022 | 662200000 | 54234000 |
| Sunday, January 1, 2023 | 910700000 | 63806000 |
Data in motion
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Viatris Inc. and Viking Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
Viatris Inc., a global healthcare company, has consistently allocated substantial resources to R&D, with expenses peaking in 2023 at approximately 910 million dollars. This represents a 56% increase from 2014, underscoring their dedication to advancing healthcare solutions.
Conversely, Viking Therapeutics, Inc., a smaller biotech firm, has shown a remarkable growth trajectory in R&D spending, increasing by nearly 187% from 2014 to 2023. Despite their smaller scale, Viking's strategic investments highlight their ambition to innovate within the biotech sector.
These trends reflect broader industry dynamics, where both established giants and nimble startups play pivotal roles in shaping the future of medicine.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
Research and Development Investment: Viatris Inc. vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Viatris Inc. and HUTCHMED (China) Limited
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs HUTCHMED (China) Limited
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xencor, Inc.